Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial-Reference-Cited by-同舟云学术

Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial

Published:2015-06 Issue:6 Volume:16 Page:729-736
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Basset-Seguin Nicole,Hauschild Axel,Grob Jean-Jacques,Kunstfeld Rainer,Dréno Brigitte,Mortier Laurent,Ascierto Paolo A,Licitra Lisa,Dutriaux Caroline,Thomas Luc,Jouary Thomas,Meyer Nicolas,Guillot Bernard,Dummer Reinhard,Fife Kate,Ernst D Scott,Williams Sarah,Fittipaldo Alberto,Xynos Ioannis,Hansson Johan

Publisher

Elsevier BV

Subject

Oncology

Reference27 articles.

1. Basal-cell carcinoma;Rubin;N Engl J Med,2005

2. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway;Sekulic;Curr Opin Oncol,2013

3. Basal cell carcinomas in a tertiary referral centre- a systematic analysis;Dreier;Br J Dermatol,2014

4. Challenges and new horizons in the management of advanced basal cell carcinoma: a UK perspective;Lear;Br J Cancer,2014

5. Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensus;Peris;Future Oncol,2015

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hedgehog Pathway and Programmed Cell Death Protein-1 Inhibitors for Advanced Basal Cell Carcinoma;Case Reports in Dermatology;2024-06-27

2. Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies;American Journal of Clinical Dermatology;2024-06-19

3. Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1;Science Advances;2024-05-03

4. Targeted therapy in ophthalmic oncology: The current status;Asia-Pacific Journal of Ophthalmology;2024-03

5. Management of Locally Invasive and Metastatic Eyelid Tumours;Oculoplastic, Lacrimal and Orbital Surgery;2024